These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16775424)

  • 41. [Familial cerebellar hemangioblastoma associated with renal cell carcinoma].
    Kubo Y; Waga S; Kojima T; Itou H; Matsubara T
    Rinsho Shinkeigaku; 1987 Nov; 27(11):1388-94. PubMed ID: 3447798
    [No Abstract]   [Full Text] [Related]  

  • 42. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors.
    Shiao YH; Rice JM; Anderson LM; Diwan BA; Hard GC
    J Natl Cancer Inst; 1998 Nov; 90(22):1720-3. PubMed ID: 9827526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The growing family of hereditary renal cell carcinoma.
    Richard S; Lidereau R; Giraud S
    Nephrol Dial Transplant; 2004 Dec; 19(12):2954-8. PubMed ID: 15507478
    [No Abstract]   [Full Text] [Related]  

  • 44. Triple pancreatic lesion in a patient with Von Hippel-Lindau disease.
    López Marcano AJ; Ramia Ángel JM; de la Plaza Llamas R; Al-Swely F; Manuel Vázquez A; García Amador C; Candia A
    Gastroenterol Hepatol; 2018; 41(7):446-448. PubMed ID: 28882614
    [No Abstract]   [Full Text] [Related]  

  • 45. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease.
    Hoang MP; Hruban RH; Albores-Saavedra J
    Am J Surg Pathol; 2001 May; 25(5):602-9. PubMed ID: 11342771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Malignant pheochromocytoma combined with multiple renal cell carcinomas and a renal cyst. Indication for von Hippel-Lindau syndrome?].
    Hofmockel G; Manseck A
    Dtsch Med Wochenschr; 2000 Jun; 125(24):767-8. PubMed ID: 10902516
    [No Abstract]   [Full Text] [Related]  

  • 49. Closing in on another renal cancer suppressor locus near chromosome 3p14.
    Kaye FJ
    J Natl Cancer Inst; 1999 Sep; 91(18):1528-9. PubMed ID: 10491421
    [No Abstract]   [Full Text] [Related]  

  • 50. Inherited renal cancer.
    Turner KJ
    BJU Int; 2000 Jul; 86(2):155-64;quiz i. PubMed ID: 10886102
    [No Abstract]   [Full Text] [Related]  

  • 51. Inherited renal neoplasms.
    Torres VE; Bjornsson J; Zincke H
    J Nephrol; 1998; 11(5):229-38. PubMed ID: 9831235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
    Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
    Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancers.
    Bailly M; Bain C; Favrot MC; Ozturk M
    Int J Cancer; 1995 Nov; 63(5):660-4. PubMed ID: 7591282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)].
    Richard S; Giraud S; Beroud C; Caron J; Penfornis F; Baudin E; Niccoli-Sire P; Murat A; Schlumberger M; Plouin PF; Conte-Devolx B
    Ann Endocrinol (Paris); 1998; 59(6):452-8. PubMed ID: 10189987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications.
    Poston CD; Jaffe GS; Lubensky IA; Solomon D; Zbar B; Linehan WM; Walther MM
    J Urol; 1995 Jan; 153(1):22-6. PubMed ID: 7966777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The von Hippel-Lindau tumor suppressor gene and kidney cancer.
    Kaelin WG
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6290S-5S. PubMed ID: 15448019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Genetic backgrounds of renal cell carcinoma].
    Oya M
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():593-6. PubMed ID: 16523961
    [No Abstract]   [Full Text] [Related]  

  • 59. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
    Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
    Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of somatic mutations in the von Hippel-Lindau (VHL) gene in a patient with renal cell carcinoma.
    Wang WC; Chen HJ; Tseng YH; Lai YC
    J Formos Med Assoc; 2009 Nov; 108(11):886-93. PubMed ID: 19933033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.